<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" open-status="O" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">World J Gastroenterol</journal-id><journal-id journal-id-type="iso-abbrev">World J. Gastroenterol</journal-id><journal-id journal-id-type="publisher-id">WJG</journal-id><journal-title-group><journal-title>World Journal of Gastroenterology</journal-title></journal-title-group><issn pub-type="ppub">1007-9327</issn><issn pub-type="epub">2219-2840</issn><publisher><publisher-name>Baishideng Publishing Group Inc</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5937203</article-id><article-id pub-id-type="other">jWJG.v24.i17.pg1859</article-id><article-id pub-id-type="doi">10.3748/wjg.v24.i17.1859</article-id><article-categories><subj-group subj-group-type="heading"><subject>Minireviews</subject></subj-group></article-categories><title-group><article-title><SecTag type="TITLE"><text><SENT sid="74070" pm="."><plain>Endoscopic management of Crohn’s strictures </plain></SENT>
</text></SecTag></article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Bessissow</surname><given-names>Talat</given-names></name><aff>Division of Gastroenterology, Department of Medicine, McGill University Health Center, Montreal, QC H3G1A4, Canada. <email>talat.bessissow@mcgill.ca</email></aff></contrib><contrib contrib-type="author"><name><surname>Reinglas</surname><given-names>Jason</given-names></name><aff>Division of Gastroenterology, Department of Medicine, McGill University Health Center, Montreal, QC H3G1A4, Canada</aff></contrib><contrib contrib-type="author"><name><surname>Aruljothy</surname><given-names>Achuthan</given-names></name><aff>Division of Gastroenterology, Department of Medicine, McGill University Health Center, Montreal, QC H3G1A4, Canada</aff></contrib><contrib contrib-type="author"><name><surname>Lakatos</surname><given-names>Peter L</given-names></name><aff>Division of Gastroenterology, Department of Medicine, McGill University Health Center, Montreal, QC H3G1A4, Canada</aff><aff>1<sup>st</sup> Department of Medicine, Semmelweis University, Budapest 1085, Hungary</aff></contrib><contrib contrib-type="author"><name><surname>Van Assche</surname><given-names>Gert</given-names></name><aff>Division of Gastroenterology and Hepatology, University Hospitals Leuven, Belgium and University of Leuven, Leuven 3000, Belgium</aff></contrib></contrib-group><author-notes><fn><p><text><SENT sid="74071" pm="."><plain>Author contributions: All authors equally contributed to this paper with conception and design of the study, literature review and analysis, drafting, critical revision, editing, and final approval of the final revision. </plain></SENT>
</text></p><p><text><SENT sid="74072" pm="."><plain>Correspondence to: Talat Bessissow, MD, CM, FRCPC, Division of Gastroenterology, Department of Medicine, McGill University Health Center, Montreal, 1650 Cedar Avenue C7-200, Montreal, QC H3G1A4, Canada. talat.bessissow@mcgill.ca </plain></SENT>
</text></p><p><text><SENT sid="74073" pm="."><plain>Telephone: +1-514-9341934 Fax: +1-514-9348531 </plain></SENT>
</text></p></fn></author-notes><pub-date pub-type="ppub"><day>7</day><month>5</month><year>2018</year></pub-date><pub-date pub-type="epub"><day>7</day><month>5</month><year>2018</year></pub-date><volume>24</volume><issue>17</issue><fpage>1859</fpage><lpage>1867</lpage><history><date date-type="received"><day>10</day><month>3</month><year>2018</year></date><date date-type="rev-recd"><day>14</day><month>4</month><year>2018</year></date><date date-type="accepted"><day>23</day><month>4</month><year>2018</year></date></history><permissions><copyright-statement>©The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved.</copyright-statement><copyright-year>2018</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/"><license-p>This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.</license-p></license></permissions><abstract><p><SecTag type="ABS"><text><SENT sid="74074" pm="."><plain>Symptomatic intestinal strictures develop in more than one third of patients with Crohn’s disease (CD) within 10 years of disease onset. </plain></SENT>
<SENT sid="74075" pm="."><plain>Strictures can be inflammatory, fibrotic or mixed and result in a significant decline in quality of life, frequently requiring surgery for palliation of symptoms. </plain></SENT>
<SENT sid="74076" pm="."><plain>Patients under the age of 40 with perianal disease are more likely to suffer from disabling ileocolonic disease thus may have a greater risk for fibrostenotic strictures. </plain></SENT>
<SENT sid="74077" pm="."><plain>Treatment options for fibrostenotic strictures are limited to endoscopic and surgical therapy. </plain></SENT>
<SENT sid="74078" pm="."><plain>Endoscopic balloon dilatation (EBD) appears to be a safe, less invasive and effective alternative modality to replace or defer surgery. </plain></SENT>
<SENT sid="74079" pm="."><plain>Serious complications are rare and occur in less than 3% of procedures. </plain></SENT>
<SENT sid="74080" pm="."><plain>For non-complex strictures without adjacent fistulizaation or perforation that are less than 5 cm in length, EBD should be considered as first-line therapy. </plain></SENT>
<SENT sid="74081" pm="."><plain>The aim of this review is to present the current literature on the endoscopic management of small bowel and colonic strictures in CD, which includes balloon dilatation, adjuvant techniques of intralesional injection of steroids and anti-tumor necrosis factor, and metal stent insertion. </plain></SENT>
<SENT sid="74082" pm="."><plain>Short and long-term outcomes, complications and safety of EBD will be discussed. </plain></SENT>
</text></SecTag></p></abstract><SecTag type="KEYWORD"><kwd-group><kwd>Endoscopy</kwd><kwd>Crohn’s disease</kwd><kwd>Stricture</kwd><kwd>Stenosis</kwd><kwd>Inflammatory bowel disease</kwd><kwd>Endoscopic balloon dilation</kwd></kwd-group></SecTag></article-meta></front><body><p><text><SENT sid="74083" pm="."><plain>Core tip: Endoscopic balloon dilation (EBD) for Crohn’s disease-related fibrostenotic strictures has been recognized as a safe, and less invasive intervention with rare complications that occur in less than 3% of procedures. </plain></SENT>
<SENT sid="74084" pm="."><plain>EBD can replace or defer surgery and help avoid frequent intestinal resections, which result in short bowel syndrome and impair quality of life. </plain></SENT>
<SENT sid="74085" pm="."><plain>For non-complex strictures without adjacent fistulization or perforation that are less than 5 cm in length, EBD should be considered as first-line therapy. </plain></SENT>
<SENT sid="74086" pm="."><plain>In this review we discuss safety, short and long-term outcomes, as well as adjuvant techniques of intralesional injection of steroids, anti-tumor necrosis factor, and metal stent insertion. </plain></SENT>
</text></p><SecTag type="INTRO"><sec><title><text><SENT sid="74087" pm="."><plain>INTRODUCTION </plain></SENT>
</text></title><p><text><SENT sid="74088" pm="."><plain>Intestinal strictures are a common complication of Crohn’s disease (CD) affecting one-third of the patient population within 10 years of disease onset. </plain></SENT>
<SENT sid="74089" pm="."><plain>This number, however, is likely under-reported[1,2]. </plain></SENT>
<SENT sid="74090" pm="."><plain>In general, CD strictures are classified into inflammatory, fibrotic or mixed, although all symptomatic inflammatory strictures likely have some component of fibrosis and vice-versa[2,3]. </plain></SENT>
<SENT sid="74091" pm="."><plain>Risk factors and predictors of intestinal strictures to date are clinical, environmental, genetic or endoscopic parameters[4] (Table 1). </plain></SENT>
<SENT sid="74092" pm="."><plain>Although no clinical factors exist which can accurately predict the stricturing phenotype of CD, there do exist factors which may predict the likelihood of small bowel disease and a disabling disease course thus indirectly may suggest an increased risk for the development of fibrostenotic disease. </plain></SENT>
<SENT sid="74093" pm="."><plain>These factors include the presence of perianal disease, age of CD diagnosis less than 40 years old and the need for steroids during the first flare[4,5]. </plain></SENT>
<SENT sid="74094" pm="."><plain>Patients frequently complain of progressive post-prandial abdominal pain, bloating, nausea, vomiting and weight loss. </plain></SENT>
<SENT sid="74095" pm="."><plain>The diagnosis of intestinal strictures usually coincides with a spiraling decline in quality of life and results in surgery in 75% of patients at least once during their lifetime[1]. </plain></SENT>
<SENT sid="74096" pm="."><plain>CD patients will frequently undergo multiple bowel resections over their lifetime that repeatedly exposes them to immediate and long-term post-operative complications such as anastomotic leaks with intra-abdominal sepsis, short bowel syndrome, and adhesions with recurrent bowel obstructions[2,6]. </plain></SENT>
</text></p><SecTag type="TABLE"><table-wrap id="T1" position="float"><label>Table 1</label><caption><p><text><SENT sid="74097" pm="."><plain>Risk factors and predictors of fibrostenosing Crohn’s disease </plain></SENT>
</text></p></caption><table frame="hsides" rules="groups"><tbody align="center"><tr><td rowspan="5" align="left" colspan="1"><text><SENT sid="74098" pm="."><plain>Clinical[4] </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74099" pm="."><plain>Age at diagnosis &lt; 40 yr </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="74100" pm="."><plain>Perianal disease at diagnosis </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="74101" pm="."><plain>Need for steroids during first flare </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="74102" pm="."><plain>Small bowel disease location </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="74103" pm="."><plain>Prior appendectomy </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="74104" pm="."><plain>Environmental[4] </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74105" pm="."><plain>Smoking </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="74106" pm="."><plain>Endoscopic[4] </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74107" pm="."><plain>Deep mucosal ulcerations </plain></SENT>
</text></td></tr><tr><td rowspan="7" align="left" colspan="1"><text><SENT sid="74108" pm="."><plain>Genetic[4] </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74109" pm="."><plain>Nucleotide oligomerisation domain 2 (NOD2) variants </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="74110" pm="."><plain>Janus-associated kinase 2 (JAK2) </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="74111" pm="."><plain>Caspase-recruitment domain 15 (CARD15) </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="74112" pm="."><plain>NOD2/CARD15 mutations on both chromosomes </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="74113" pm="."><plain>TNF superfamily 15 (TNFSF15) in Asians </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="74114" pm="."><plain>5T5T in the MMP3 gene </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="74115" pm="."><plain>rs1363670 </plain></SENT>
</text></td></tr><tr><td rowspan="2" align="left" colspan="1"><text><SENT sid="74116" pm="."><plain>Serological[4] </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74117" pm="."><plain>Antimicrobial antibodies </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="74118" pm="."><plain>anti-Saccharomyces cerevisiae antibodies (ASCA) IgA in Asians </plain></SENT>
</text></td></tr></tbody></table></table-wrap></SecTag><p><text><SENT sid="74119" pm="."><plain>The pathogenesis of CD complications develops from chronic accumulation of inflammatory bowel damage variably leading to stricture, fistula and/or abscess formation[2]. </plain></SENT>
<SENT sid="74120" pm="."><plain>Stricture development, although not fully understood, involves the progressive deposition of extracellular matrix protein (ECM) produced by myofibroblasts at variable sites of the bowel being injured by chronically uncontrolled relapsing and remitting transmural inflammation[7]. </plain></SENT>
<SENT sid="74121" pm="."><plain>During chronic intestinal inflammation, the baseline release of profibrotic cytokines (e.g., IL-4 and IL-13) increases over time further accelerating the process of excessive matrix deposition[7,8]. </plain></SENT>
<SENT sid="74122" pm="."><plain>There may also exist a point where inflammation is no longer required to trigger fibrosis. </plain></SENT>
<SENT sid="74123" pm="."><plain>As ECM is deposited during chronic inflammation, the bowel wall becomes stiffer. </plain></SENT>
<SENT sid="74124" pm="."><plain>Bowel wall stiffness acts independently as a mesenchymal cell activator, resulting in ongoing myofibroblast stimulation, thus progressive fibrotic stenosis[9]. </plain></SENT>
</text></p><p><text><SENT sid="74125" pm="."><plain>Treatment options for fibrostenotic strictures are limited to endoscopic and surgical therapy (i.e., stricturoplasty and small bowel resection)[10]. </plain></SENT>
<SENT sid="74126" pm="."><plain>Fortunately, most de novo strictures form in the ileum and ileocolic regions, which are accessible by ileocolonoscopy or balloon-assisted enteroscopy[11]. </plain></SENT>
<SENT sid="74127" pm="."><plain>Although pharmacotherapy may delay the time before operative management, it has not been shown to prevent it[12]. </plain></SENT>
<SENT sid="74128" pm="."><plain>Approximately 80% of patients will have their first bowel resection 10 years following their diagnosis of CD[2]. </plain></SENT>
<SENT sid="74129" pm="."><plain>To date no specific intestinal anti-fibrotic therapy exists, nor has any immunosuppressant or biologic therapy been shown to prevent stricture formation. </plain></SENT>
</text></p><p><text><SENT sid="74130" pm="."><plain>The following review presents the current data on the endoscopic management of small bowel and colonic strictures in CD. </plain></SENT>
<SENT sid="74131" pm="."><plain>Short and long-term outcomes, complications and a description of the procedure will be discussed. </plain></SENT>
</text></p></sec></SecTag><sec><title><text><SENT sid="74132" pm="."><plain>EFFICACY OF ENDOSCOPIC BALLOON DILATION </plain></SENT>
</text></title><p><text><SENT sid="74133" pm="."><plain>Endoscopic balloon dilation (EBD) is a minimally invasive bowel-length preserving mean of managing symptomatic CD patients with short fibrotic strictures (Figure 1). </plain></SENT>
<SENT sid="74134" pm="."><plain>EBD has become an established modality of therapy and often plays an important role in delaying or acting as a bridge to surgery[10,13]. </plain></SENT>
<SENT sid="74135" pm="."><plain>The most common location of the small bowel to undergo EBD using a colonoscope is the distal ileum or at the ileocolonic anastomosis of a patient following a small bowel resection[14]. </plain></SENT>
<SENT sid="74136" pm="."><plain>Strictures located in the distal duodenum to proximal jejunum or distal jejunum to proximal ileum may be accessed with ante- or retrograde enteroscopy, respectively[15]. </plain></SENT>
</text></p><SecTag type="FIG"><fig id="F1" position="float"><label>Figure 1</label><caption><p><text><SENT sid="74137" pm="."><plain>Endoscopic balloon dilatation of ileocolonic anastomosis (A) and endoscopic appearance post endoscopic dilatation (B). </plain></SENT>
</text></p></caption><graphic xlink:href="WJG-24-1859-g001"/></fig></SecTag><p><text><SENT sid="74138" pm="."><plain>Short- and long-term efficacy has been inconsistently defined in studies[13]. </plain></SENT>
<SENT sid="74139" pm="."><plain>In general, short-term efficacy has been described as the technical success of the procedure or the ability to traverse the dilated area freely with the endoscope immediately after dilatation[13,16]. </plain></SENT>
<SENT sid="74140" pm="."><plain>Long-term efficacy, in most studies, has been described as the time elapsed until another intervention (either surgical or endoscopic) is required[2,13,16]. </plain></SENT>
<SENT sid="74141" pm="."><plain>Despite the lack of a formal definition, excellent short- and moderate long-term efficacy of EBD for CD strictures has been documented in many studies[14,16,17]. </plain></SENT>
<SENT sid="74142" pm="."><plain>Table 2 shows a summary of published studies on EBD using conventional colonoscopy in CD patients. </plain></SENT>
<SENT sid="74143" pm="."><plain>In a systematic review and descriptive pooled analysis of 12 studies conducted between 1991 to 2013 evaluating 1463 CD patients who underwent 3213 EBD procedures, the technical success rate was 89% with an associated relief of clinical symptoms in 81% of patients[14]. </plain></SENT>
<SENT sid="74144" pm="."><plain>The majority of strictures were ileal (98.6%) at anastomotic sites (62%), which were 2 cm or less. </plain></SENT>
<SENT sid="74145" pm="."><plain>However, the recurrence rate of strictures was high. </plain></SENT>
<SENT sid="74146" pm="."><plain>At the 36.6 mo median follow-up, 47.5% of patients had symptomatic recurrence and 28.6% of all patients had required surgical intervention. </plain></SENT>
<SENT sid="74147" pm="."><plain>This study concluded that the chance of requiring repeat EBD or surgical intervention at 2 years was 73.5% and 42.9%, respectively[14]. </plain></SENT>
<SENT sid="74148" pm="."><plain>Another large recent systematic review with meta-analysis involving 1089 patients (2664 EBDs) across 25 studies revealed similar results[17]. </plain></SENT>
<SENT sid="74149" pm="."><plain>The technical success rate was 92.3% with a reported symptomatic response rate of 70.4%. </plain></SENT>
<SENT sid="74150" pm="."><plain>The proportion of patients requiring a repeat dilation after 1 and 2 years was 31.6% (160/506) and 25.9% (117/451), respectively. </plain></SENT>
<SENT sid="74151" pm="."><plain>Most patients within 5 years required recurrent dilations (80%) and/or surgical interventions (75%)[17]. </plain></SENT>
<SENT sid="74152" pm="."><plain>Of interest is the lower symptomatic success rate as compared to the technical success rate across studies. </plain></SENT>
<SENT sid="74153" pm="."><plain>This likely occurred due to a lack of a standardized means of reporting technical and clinical efficacy and/or a superimposed process existing that contributed to the patient’s symptoms (e.g., ongoing inflammation, intestinal bacterial overgrowth, IBS, etc.)[10]. </plain></SENT>
<SENT sid="74154" pm="."><plain>Despite this discrepancy, the short-term clinical success rate remains high. </plain></SENT>
</text></p><SecTag type="TABLE"><table-wrap id="T2" position="float"><label>Table 2</label><caption><p><text><SENT sid="74155" pm="."><plain>Summary of published studies on endoscopic balloon for Crohn’s disease strictures </plain></SENT>
</text></p></caption><table frame="hsides" rules="groups"><thead align="center"><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="74156" pm="."><plain>Authors </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74157" pm="."><plain>Pubished year </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74158" pm="."><plain>No. of patients </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74159" pm="."><plain>Anastomotic strictures (%) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74160" pm="."><plain>Maximum balloon caliber (mm) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74161" pm="."><plain>Technical success (%) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74162" pm="."><plain>Clinical efficacy (%) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74163" pm="."><plain>Major complication (%) </plain></SENT>
</text></td></tr></thead><tbody align="center"><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="74164" pm="."><plain>Blomberg et al[52] </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74165" pm="."><plain>1991 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74166" pm="."><plain>27 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74167" pm="."><plain>100 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74168" pm="."><plain>25 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74169" pm="."><plain>100 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74170" pm="."><plain>67 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74171" pm="."><plain>0 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="74172" pm="."><plain>Williams et al[53] </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74173" pm="."><plain>1991 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74174" pm="."><plain>7 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74175" pm="."><plain>71 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74176" pm="."><plain>20 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74177" pm="."><plain>71 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74178" pm="."><plain>71 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74179" pm="."><plain>0 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="74180" pm="."><plain>Breysem et al[54] </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74181" pm="."><plain>1992 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74182" pm="."><plain>18 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74183" pm="."><plain>78 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74184" pm="."><plain>18 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74185" pm="."><plain>89 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74186" pm="."><plain>50 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74187" pm="."><plain>0 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="74188" pm="."><plain>Cockuyt et al[55] </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74189" pm="."><plain>1995 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74190" pm="."><plain>55 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74191" pm="."><plain>67 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74192" pm="."><plain>20 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74193" pm="."><plain>85 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74194" pm="."><plain>62 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74195" pm="."><plain>8 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="74196" pm="."><plain>Ramboer et al[56] </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74197" pm="."><plain>1995 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74198" pm="."><plain>13 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74199" pm="."><plain>69 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74200" pm="."><plain>18 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74201" pm="."><plain>100 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74202" pm="."><plain>100 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74203" pm="."><plain>0 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="74204" pm="."><plain>Matsui et al[57] </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74205" pm="."><plain>2000 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74206" pm="."><plain>55 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74207" pm="."><plain>43 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74208" pm="."><plain>20 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74209" pm="."><plain>86 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74210" pm="."><plain>78 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74211" pm="."><plain>2 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="74212" pm="."><plain>Dear et al[58] </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74213" pm="."><plain>2001 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74214" pm="."><plain>22 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74215" pm="."><plain>95 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74216" pm="."><plain>18 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74217" pm="."><plain>100 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74218" pm="."><plain>73 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74219" pm="."><plain>0 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="74220" pm="."><plain>Brooker et al[59] </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74221" pm="."><plain>2003 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74222" pm="."><plain>14 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74223" pm="."><plain>79 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74224" pm="."><plain>20 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74225" pm="."><plain>100 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74226" pm="."><plain>79 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74227" pm="."><plain>0 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="74228" pm="."><plain>Morini et al[60] </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74229" pm="."><plain>2003 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74230" pm="."><plain>43 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74231" pm="."><plain>67 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74232" pm="."><plain>18 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74233" pm="."><plain>79 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74234" pm="."><plain>42 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74235" pm="."><plain>0 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="74236" pm="."><plain>Sabate et al[61] </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74237" pm="."><plain>2003 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74238" pm="."><plain>38 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74239" pm="."><plain>68 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74240" pm="."><plain>25 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74241" pm="."><plain>84 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74242" pm="."><plain>53 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74243" pm="."><plain>3 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="74244" pm="."><plain>Thomas-Gibson et al[62] </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74245" pm="."><plain>2003 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74246" pm="."><plain>59 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74247" pm="."><plain>90 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74248" pm="."><plain>18 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74249" pm="."><plain>73 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74250" pm="."><plain>41 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74251" pm="."><plain>3 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="74252" pm="."><plain>Singh et al[63] </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74253" pm="."><plain>2005 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74254" pm="."><plain>17 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74255" pm="."><plain>35 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74256" pm="."><plain>20 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74257" pm="."><plain>100 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74258" pm="."><plain>76 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74259" pm="."><plain>18 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="74260" pm="."><plain>Aljouni et al[64] </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74261" pm="."><plain>2006 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74262" pm="."><plain>37 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74263" pm="."><plain>37 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74264" pm="."><plain>20 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74265" pm="."><plain>90 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74266" pm="."><plain>87 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74267" pm="."><plain>3 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="74268" pm="."><plain>Ferlitsch et al[65] </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74269" pm="."><plain>2006 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74270" pm="."><plain>46 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74271" pm="."><plain>59 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74272" pm="."><plain>20 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74273" pm="."><plain>85 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74274" pm="."><plain>66 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74275" pm="."><plain>4 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="74276" pm="."><plain>Nomura et al[66] </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74277" pm="."><plain>2006 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74278" pm="."><plain>16 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74279" pm="."><plain>35 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74280" pm="."><plain>20 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74281" pm="."><plain>94 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74282" pm="."><plain>65 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74283" pm="."><plain>6 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="74284" pm="."><plain>Foster et al[67] </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74285" pm="."><plain>2008 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74286" pm="."><plain>24 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74287" pm="."><plain>41 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74288" pm="."><plain>20 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74289" pm="."><plain>92 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74290" pm="."><plain>NA </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74291" pm="."><plain>13 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="74292" pm="."><plain>Hoffman et al[68] </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74293" pm="."><plain>2008 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74294" pm="."><plain>25 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74295" pm="."><plain>57 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74296" pm="."><plain>20 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74297" pm="."><plain>100 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74298" pm="."><plain>52 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74299" pm="."><plain>16 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="74300" pm="."><plain>Stienecker et al[69] </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74301" pm="."><plain>2009 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74302" pm="."><plain>25 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74303" pm="."><plain>42 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74304" pm="."><plain>18 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74305" pm="."><plain>97 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74306" pm="."><plain>94 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74307" pm="."><plain>3 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="74308" pm="."><plain>Mueller et al[70] </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74309" pm="."><plain>2010 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74310" pm="."><plain>55 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74311" pm="."><plain>23 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74312" pm="."><plain>18 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74313" pm="."><plain>95 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74314" pm="."><plain>76 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74315" pm="."><plain>2 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="74316" pm="."><plain>Thienpont et al[71] </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74317" pm="."><plain>2010` </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74318" pm="."><plain>138 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74319" pm="."><plain>84 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74320" pm="."><plain>18 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74321" pm="."><plain>97 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74322" pm="."><plain>76 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74323" pm="."><plain>3 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="74324" pm="."><plain>Scimeca et al[72] </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74325" pm="."><plain>2011 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74326" pm="."><plain>37 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74327" pm="."><plain>90 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74328" pm="."><plain>20 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74329" pm="."><plain>84 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74330" pm="."><plain>89 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74331" pm="."><plain>0 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="74332" pm="."><plain>Gustavsson et al[51] </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74333" pm="."><plain>2012 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74334" pm="."><plain>178 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74335" pm="."><plain>80 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74336" pm="."><plain>25 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74337" pm="."><plain>89 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74338" pm="."><plain>64 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74339" pm="."><plain>11 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="74340" pm="."><plain>Karstensen et al[73] </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74341" pm="."><plain>2012 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74342" pm="."><plain>23 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74343" pm="."><plain>24 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74344" pm="."><plain>15 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74345" pm="."><plain>83 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74346" pm="."><plain>74 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74347" pm="."><plain>1.9 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="74348" pm="."><plain>De’Angelis et al[74] </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74349" pm="."><plain>2013 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74350" pm="."><plain>26 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74351" pm="."><plain>52 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74352" pm="."><plain>18 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74353" pm="."><plain>100 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74354" pm="."><plain>93 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74355" pm="."><plain>2 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="74356" pm="."><plain>Endo et al[75] </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74357" pm="."><plain>2013 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74358" pm="."><plain>30 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74359" pm="."><plain>36 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74360" pm="."><plain>20 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74361" pm="."><plain>94 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74362" pm="."><plain>64 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74363" pm="."><plain>10 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="74364" pm="."><plain>Honzawa et al[76] </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74365" pm="."><plain>2013 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74366" pm="."><plain>25 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74367" pm="."><plain>21 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74368" pm="."><plain>20 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74369" pm="."><plain>88 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74370" pm="."><plain>62 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74371" pm="."><plain>12 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="74372" pm="."><plain>Nanda et al[77] </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74373" pm="."><plain>2013 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74374" pm="."><plain>31 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74375" pm="."><plain>100 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74376" pm="."><plain>18 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74377" pm="."><plain>100 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74378" pm="."><plain>45 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74379" pm="."><plain>0 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="74380" pm="."><plain>Atreja et al[78] </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74381" pm="."><plain>2014 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74382" pm="."><plain>128 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74383" pm="."><plain>48 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74384" pm="."><plain>20 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74385" pm="."><plain>83 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74386" pm="."><plain>67 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74387" pm="."><plain>3 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="74388" pm="."><plain>Bhalme et al[79] </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74389" pm="."><plain>2014 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74390" pm="."><plain>79 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74391" pm="."><plain>61 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74392" pm="."><plain>20 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74393" pm="."><plain>95 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74394" pm="."><plain>77 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74395" pm="."><plain>0 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="74396" pm="."><plain>Hagel et al[80] </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74397" pm="."><plain>2014 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74398" pm="."><plain>77 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74399" pm="."><plain>57 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74400" pm="."><plain>20 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74401" pm="."><plain>55 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74402" pm="."><plain>65 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74403" pm="."><plain>10 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="74404" pm="."><plain>Krauss et al[81] </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74405" pm="."><plain>2014 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74406" pm="."><plain>20 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74407" pm="."><plain>25 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74408" pm="."><plain>18 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74409" pm="."><plain>100 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74410" pm="."><plain>NA </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74411" pm="."><plain>14 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="74412" pm="."><plain>Ding et al[82] </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74413" pm="."><plain>2016 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74414" pm="."><plain>54 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74415" pm="."><plain>100 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74416" pm="."><plain>20 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74417" pm="."><plain>89 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74418" pm="."><plain>82 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74419" pm="."><plain>2 </plain></SENT>
</text></td></tr></tbody></table><table-wrap-foot><fn><p><text><SENT sid="74420" pm="."><plain>Clinical efficacy was defined according to each study (i.e., resolution of obstructive symptoms after dilation with the avoidance of surgery or additional intervention). </plain></SENT>
<SENT sid="74421" pm="."><plain>Technical success was defined by successful passage of the endoscope or colonoscope immediately after dilation. </plain></SENT>
<SENT sid="74422" pm="."><plain>Clinical efficacy was defined as the resolution of obstructive symptoms after dilation with the avoidance of surgery. </plain></SENT>
<SENT sid="74423" pm="."><plain>Major complications (calculated per number of dilations) included were perforations, bleeding, intra-abdominal abscesses or fistulas. </plain></SENT>
<SENT sid="74424" pm="."><plain>NA: Not available. </plain></SENT>
</text></p></fn></table-wrap-foot></table-wrap></SecTag><p><text><SENT sid="74425" pm="."><plain>In the setting of small bowel strictures not in reach of the enteroscope or colonoscope, the double balloon enteroscope can be used in an antegrade or retrograde fashion for diagnostic and/or therapeutic intervention[15]. </plain></SENT>
<SENT sid="74426" pm="."><plain>Although there are only a few small studies which have evaluated its use in dilating small bowel CD strictures, the results were positive[18,19]. </plain></SENT>
<SENT sid="74427" pm="."><plain>Nishida et al[20] performed a retrospective review on their center’s experience with dilating small bowel strictures between 2006 to 2015. </plain></SENT>
<SENT sid="74428" pm="."><plain>Overall, small bowel dilation using the double balloon enteroscope was found to be successful but there was a greater risk for requiring surgery in patients with multiple strictures as compared to those with a single stricture (adjusted hazard ratio, 14.94; 95%CI: 1.91-117.12; P = 0.010)[20]. </plain></SENT>
<SENT sid="74429" pm="."><plain>As such, a single stricture but not necessarily multiple strictures may be a good indication for considering dilation using the double balloon enteroscope. </plain></SENT>
</text></p></sec><sec><title><text><SENT sid="74430" pm="."><plain>PREDICTORS OF SUCCESSFUL ENDOSCOPIC DILATATION </plain></SENT>
</text></title><p><text><SENT sid="74431" pm="."><plain>Factors that are predictive of a successful EBD include short straight strictures in-line with the bowel lumen distal to the duodenum, which are non-ulcerated in a location without any adjacent abscess and at least 5 cm from a fistula orifice[21,22]. </plain></SENT>
<SENT sid="74432" pm="."><plain>Strictures located in the duodenum were found to have a 5 fold increased hazard for time to shorter surgery as compared to strictures located in the jejunum/ileum or colon (HR = 4.7, P = 0.038; HR = 5.6, P = 0.03; respectively)[23]. </plain></SENT>
<SENT sid="74433" pm="."><plain>Additionally, a stricture length ≤ 5 cm was associated with a lower chance of requiring surgical intervention following EBD (HR = 2.5, 95%CI: 1.4-4.4; P = 0.002). </plain></SENT>
<SENT sid="74434" pm="."><plain>For every 1 cm increase in stricture length, the risk for surgery increased by 8% (P = 0.005)[23]. </plain></SENT>
<SENT sid="74435" pm="."><plain>In contrast to popular belief, anastomotic strictures have been associated with poorer short-term outcomes than de novo strictures[23,24]. </plain></SENT>
<SENT sid="74436" pm="."><plain>This was highlighted in the aforementioned review by Bettenworth et al[14] which documented a lower technical success rate for post-surgical strictures as compared to native strictures (OR = 2.3, P &lt; 0.001). </plain></SENT>
<SENT sid="74437" pm="."><plain>Similarly, a recent study published by the Cleveland Clinic group after performing a retrospective review on 307 patients who had undergone either EBD or surgical resection for an ileocolonic anastomotic stricture had worse short-term outcomes (i.e., technical success) but similar long-term outcomes as compared to the aforementioned studies evaluating EBD of de novo strictures[24]. </plain></SENT>
<SENT sid="74438" pm="."><plain>Of the 176 patients who had undergone EBD, the technical success rate was 86% (range 71% to 100%) with a long-term clinical efficacy, defined as an avoidance of surgery, of 58% over a follow-up period of 33 mo[24]. </plain></SENT>
<SENT sid="74439" pm="."><plain>The presence of active inflammation identified on endoscopy, elevated CRP, medical treatment after dilation, cigarette smoking and intralesional steroid injection have demonstrated conflicting results with respect to the need for surgery and successful EBD[2,17,23,24]. </plain></SENT>
</text></p></sec><sec><title><text><SENT sid="74440" pm="."><plain>ENDOSCOPIC ADJUVANT TECHNIQUES </plain></SENT>
</text></title><p><text><SENT sid="74441" pm="."><plain>Intralesional injection of steroids has been demonstrated to be effective for peptic, corrosive, anastomotic or post-radiotherapy fibrotic strictures[25]. </plain></SENT>
<SENT sid="74442" pm="."><plain>However, strong evidence for the use of intralesional injection of steroids in CD is lacking[25-28]. </plain></SENT>
<SENT sid="74443" pm="."><plain>Studies that have evaluated its use in CD have used the formulation triamcinolone due to its rapid onset of action and long-lasting duration of effectiveness of 3-4 wk[29]. </plain></SENT>
<SENT sid="74444" pm="."><plain>Only two small randomized placebo controlled studies have been performed evaluating the use of intralesional steroids versus saline injection after failing medical therapy and EBD. </plain></SENT>
<SENT sid="74445" pm="."><plain>The first study conducted in 2007, included 13 adult patients with short (≤ 5 cm) ileocolonic anastomotic strictures[30]. </plain></SENT>
<SENT sid="74446" pm="."><plain>Five of the seven patients in the intervention group required re-dilation after the procedure and one patient had a complication versus one of six in the placebo group required re-dilation. </plain></SENT>
<SENT sid="74447" pm="."><plain>There was no significant difference with respect to success of the procedure between groups[30]. </plain></SENT>
<SENT sid="74448" pm="."><plain>This trial was stopped early due to the trend toward harm and remains the influential study behind the current American College of Gastroenterology and British Society of Gastroenterology position statements against the routine use of intralesional steroids[31,32]. </plain></SENT>
<SENT sid="74449" pm="."><plain>The second study published in 2010 included 29 pediatric patients with short ileal or colonic strictures (12 anastomotic, 17 de novo)[33]. </plain></SENT>
<SENT sid="74450" pm="."><plain>In contrast, this study did demonstrate a reduction in time to re-dilation and surgery in the intervention group. </plain></SENT>
<SENT sid="74451" pm="."><plain>Within the sub-group of patients evaluated in a recent large systematic review evaluating the management of CD strictures, intralesional steroid injection did not improve outcomes[33]. </plain></SENT>
<SENT sid="74452" pm="."><plain>Similarly, a review conducted in 2013 summarizing the findings from five retrospective case-series evaluating the use of intralesional steroids in CD patients concluded the data to be contradictory and limited[34]. </plain></SENT>
</text></p><p><text><SENT sid="74453" pm="."><plain>Although controversial, intralesional injection of anti-tumor necrosis factor has been evaluated in patients with small bowel and colonic CD strictures with promising results, but concerns related to immunization may limit its potential as a therapeutic option[35,36]. </plain></SENT>
<SENT sid="74454" pm="."><plain>One small case series evaluated the effect of a 90-120 mg intralesional injection of infliximab in three symptomatic patients with colonic CD strictures. </plain></SENT>
<SENT sid="74455" pm="."><plain>All three patients had an improved endoscopic appearance of the stricture as well as relief of their obstructive symptoms for at least four months following the injection[35]. </plain></SENT>
<SENT sid="74456" pm="."><plain>Similarly, another small case series evaluating intralesional injections of 40 mg of infliximab into small bowel CD strictures combined with EBD in six patients was associated with improved symptoms and a reduction in their modified simple endoscopic score for Crohn’s disease (SES-CD)[37]. </plain></SENT>
<SENT sid="74457" pm="."><plain>The results of a larger randomized controlled trial evaluating the efficacy of performing intralesional injections of adalimumab into intestinal CD strictures are awaited[38]. </plain></SENT>
</text></p><p><text><SENT sid="74458" pm="."><plain>Endoscopic metal stent insertion has been attempted in few patients with CD strictures. </plain></SENT>
<SENT sid="74459" pm="."><plain>Although the technical success rate has been reportedly high, major complications such as bowel perforation, stent migration and fistulization was reported in 67% of patients[39]. </plain></SENT>
<SENT sid="74460" pm="."><plain>Additionally, in order to avoid stent impaction, most studies suggest removing the stent after one month[40-42]. </plain></SENT>
<SENT sid="74461" pm="."><plain>One small prospective cohort study concluded the risk for complications was too high to suggest the use of endoscopic metal stents as a treatment option for CD strictures after evaluating the data from 11 patients at their center[40]. </plain></SENT>
<SENT sid="74462" pm="."><plain>The use of biodegradable instead of metal stents has been evaluated recently in a case-series last year involving six patients with intestinal and colonic CD strictures. </plain></SENT>
<SENT sid="74463" pm="."><plain>Although technical success was good, premature stent failure occurred in all of the patients[43]. </plain></SENT>
</text></p></sec><sec><title><text><SENT sid="74464" pm="."><plain>SAFETY OF ENDOSCOPIC BALLOON DILATION </plain></SENT>
</text></title><p><text><SENT sid="74465" pm="."><plain>Although EBD is a minimally invasive procedure, bowel perforation and severe bleeding has been reported in most large studies[17,23,24]. </plain></SENT>
<SENT sid="74466" pm="."><plain>In the aforementioned review by Bettenworth et al[14], major complications requiring hospitalization occurred in 2.8% of patients. </plain></SENT>
<SENT sid="74467" pm="."><plain>Similarly, another large systematic review evaluating 24 non-randomized studies including 1163 patients found the rate of iatrogenic perforation to be 3%[44]. </plain></SENT>
<SENT sid="74468" pm="."><plain>The rate for major complications including infection and hemorrhage in this study was 4%[44]. </plain></SENT>
<SENT sid="74469" pm="."><plain>In a study directly comparing EBD to surgical intervention for the management of intestinal CD strictures, perforation occurred in 1.1% of the patients in the EBD group whereas the post-operative complication rate (e.g., intra-abdominal sepsis) was 8.8%[24]. </plain></SENT>
<SENT sid="74470" pm="."><plain>Despite these significant complications, no deaths have been reported to date. </plain></SENT>
<SENT sid="74471" pm="."><plain>Since benign or inflammatory intestinal strictures are indistinguishable from early adenocarcinoma on imaging, there exists a risk that malignancy may be missed when EBD is performed instead of surgical excision[3]. </plain></SENT>
<SENT sid="74472" pm="."><plain>Population based studies have suggested a greater risk for small bowel malignancy in patients with longstanding CD. </plain></SENT>
<SENT sid="74473" pm="."><plain>Several case reports exist documenting the development of small bowel malignancy following stricturoplasty and bypassed loops[45-51]. </plain></SENT>
<SENT sid="74474" pm="."><plain>As such, biopsies of the stricture should occur prior to dilation[22]. </plain></SENT>
<SENT sid="74475" pm="."><plain>There has been no evidence to suggest obtaining biopsies prior to EBD increases the risk for perforation. </plain></SENT>
</text></p></sec><SecTag type="CONCL"><sec><title><text><SENT sid="74476" pm="."><plain>CONCLUSION </plain></SENT>
</text></title><p><text><SENT sid="74477" pm="."><plain>EBD remains a safe and effective modality of treating CD strictures in appropriately selected patients. </plain></SENT>
<SENT sid="74478" pm="."><plain>Although it may not be able to prevent operative management in all patients, it can significantly delay it. </plain></SENT>
<SENT sid="74479" pm="."><plain>For an isolated intestinal fibrostenotic CD stricture less than or equal to 5 cm in length without adjacent fistulization or perforation, EBD should be considered as first-line therapy (Table 3). </plain></SENT>
</text></p><SecTag type="TABLE"><table-wrap id="T3" position="float"><label>Table 3</label><caption><p><text><SENT sid="74480" pm="."><plain>Practical considerations </plain></SENT>
</text></p></caption><table frame="hsides" rules="groups"><tbody align="center"><tr><td rowspan="7" align="left" colspan="1"><text><SENT sid="74481" pm="."><plain>Predictors favoring successful dilation[11,22-25] </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74482" pm="."><plain>Symptomatic predominantly fibrotic stricture </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="74483" pm="."><plain>Short (≤ 5 cm) stricture </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="74484" pm="."><plain>Single straight stricture </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="74485" pm="."><plain>Stricture distal to the duodenum </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="74486" pm="."><plain>Anastomotic stricture more favorable than de novo stricture </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="74487" pm="."><plain>First dilation </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="74488" pm="."><plain>Lack of a superimposed process contributing to symptoms (e.g., SIBO or IBS) </plain></SENT>
</text></td></tr><tr><td rowspan="9" align="left" colspan="1"><text><SENT sid="74489" pm="."><plain>Risk factors for complications[22-25] </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74490" pm="."><plain>Predominantly inflammatory stricture without medical optimization </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="74491" pm="."><plain>Stricture greater than 5 cm </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="74492" pm="."><plain>Multiple small bowel strictures </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="74493" pm="."><plain>Strictures caused by extrinsic compression (e.g., adhesions) </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="74494" pm="."><plain>Fistulization within 5 cm of the area to be dilated </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="74495" pm="."><plain>Adjacent perforation or intra-abdominal collection </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="74496" pm="."><plain>Complete small bowel obstruction </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="74497" pm="."><plain>Tortuous or tethered small bowel or significant stricture angulation </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="74498" pm="."><plain>Duodenal stricture </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="74499" pm="."><plain>1Short term outcome[15,18] </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74500" pm="."><plain>85%-95% (technical success), 70%-80% (clinical response) </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="74501" pm="."><plain>2Long term outcome[15,18] </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74502" pm="."><plain>32% (year 1 post dilation), 80% (year 5 post dilation) </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="74503" pm="."><plain>3Complication rate[25,45] </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74504" pm="."><plain>1%-4% </plain></SENT>
</text></td></tr></tbody></table><table-wrap-foot><fn id="T3FN1"><label>1</label><p><text><SENT sid="74505" pm="."><plain>Short term outcome refers to the time elapsed immediately after the dilation takes place; technical success refers to the ability to successfully complete the dilation; clinical response refers to the symptomatic improvement of the patient immediately following the dilation; </plain></SENT>
</text></p></fn><fn id="T3FN2"><label>2</label><p><text><SENT sid="74506" pm="."><plain>Long term outcome refers to the percentage of patients requiring a repeat intervention; </plain></SENT>
</text></p></fn><fn id="T3FN3"><label>3</label><p><text><SENT sid="74507" pm="."><plain>Complication rate encompasses only major complications requiring urgent intervention such as bleeding, perforation and infection. </plain></SENT>
</text></p></fn></table-wrap-foot></table-wrap></SecTag></sec></SecTag></body><back><fn-group><fn><p><text><SENT sid="74508" pm="."><plain>Manuscript source: Invited manuscript </plain></SENT>
</text></p></fn><fn><p><text><SENT sid="74509" pm="."><plain>Specialty type: Gastroenterology and hepatology </plain></SENT>
</text></p></fn><fn><p><text><SENT sid="74510" pm="."><plain>Country of origin: Canada </plain></SENT>
</text></p></fn><fn><p><text><SENT sid="74511" pm="."><plain>Peer-review report classification </plain></SENT>
</text></p></fn><fn><p><text><SENT sid="74512" pm="."><plain>Grade A (Excellent): A, A </plain></SENT>
</text></p></fn><fn><p><text><SENT sid="74513" pm="."><plain>Grade B (Very good): B, B </plain></SENT>
</text></p></fn><fn><p><text><SENT sid="74514" pm="."><plain>Grade C (Good): 0 </plain></SENT>
</text></p></fn><fn><p><text><SENT sid="74515" pm="."><plain>Grade D (Fair): 0 </plain></SENT>
</text></p></fn><fn><p><text><SENT sid="74516" pm="."><plain>Grade E (Poor): 0 </plain></SENT>
</text></p></fn><fn fn-type="COI-statement"><p><text><SENT sid="74517" pm="."><plain>Conflict-of-interest statement: None. </plain></SENT>
</text></p></fn><fn><p><text><SENT sid="74518" pm="."><plain>Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. </plain></SENT>
<SENT sid="74519" pm="."><plain>It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. </plain></SENT>
<SENT sid="74520" pm="."><plain>See: http://creativecommons.org/licenses/by-nc/4.0/ </plain></SENT>
</text></p></fn><fn><p><text><SENT sid="74521" pm="."><plain>Peer-review started: March 11, 2018 </plain></SENT>
</text></p></fn><fn><p><text><SENT sid="74522" pm="."><plain>First decision: March 29, 2018 </plain></SENT>
</text></p></fn><fn><p><text><SENT sid="74523" pm="."><plain>Article in press: April 23, 2018 </plain></SENT>
</text></p></fn><fn><p><text><SENT sid="74524" pm="."><plain>P- Reviewer: Gangl A, M’Koma A, Souza JL, Wittmann T S- Editor: Gong ZM L- Editor: A E- Editor: Huang Y </plain></SENT>
</text></p></fn></fn-group><SecTag type="REF"><ref-list><ref id="B1"><text><SENT sid="74525" pm="."><plain>1CosnesJCattanSBlainABeaugerieLCarbonnelFParcRGendreJPLong-term evolution of disease behavior of Crohn’s diseaseInflamm Bowel Dis2002824425012131607 </plain></SENT>
</text></ref><ref id="B2"><text><SENT sid="74526" pm="."><plain>2RiederFZimmermannEMRemziFHSandbornWJCrohn’s disease complicated by strictures: a systematic reviewGut2013621072108423626373 </plain></SENT>
</text></ref><ref id="B3"><text><SENT sid="74527" pm="."><plain>3BettenworthDNowackiTMCordesFBuerkeBLenzeFAssessment of stricturing Crohn’s disease: Current clinical practice and future avenuesWorld J Gastroenterol2016221008101626811643 </plain></SENT>
</text></ref><ref id="B4"><text><SENT sid="74528" pm="."><plain>4RiederFLawranceICLeiteASansMPredictors of fibrostenotic Crohn’s diseaseInflamm Bowel Dis2011172000200721308880 </plain></SENT>
</text></ref><ref id="B5"><text><SENT sid="74529" pm="."><plain>5BurkeJPMulsowJJO’KeaneCDochertyNGWatsonRWO’ConnellPRFibrogenesis in Crohn’s diseaseAm J Gastroenterol200710243944817156147 </plain></SENT>
</text></ref><ref id="B6"><text><SENT sid="74530" pm="."><plain>6ShivanandaSHordijkMLPenaASMayberryJFCrohn’s disease: risk of recurrence and reoperation in a defined populationGut1989309909952759493 </plain></SENT>
</text></ref><ref id="B7"><text><SENT sid="74531" pm="."><plain>7FiocchiCLundPKThemes in fibrosis and gastrointestinal inflammationAm J Physiol Gastrointest Liver Physiol2011300G677G68321415411 </plain></SENT>
</text></ref><ref id="B8"><text><SENT sid="74532" pm="."><plain>8GrahamMFDiegelmannRFElsonCOLindbladWJGotschalkNGaySGayRCollagen content and types in the intestinal strictures of Crohn’s diseaseGastroenterology1988942572653335305 </plain></SENT>
</text></ref><ref id="B9"><text><SENT sid="74533" pm="."><plain>9WellsRGThe role of matrix stiffness in regulating cell behaviorHepatology2008471394140018307210 </plain></SENT>
</text></ref><ref id="B10"><text><SENT sid="74534" pm="."><plain>10GionchettiPDignassADaneseSMagro DiasFJRoglerGLakatosPLAdaminaMArdizzoneSBuskensCJSebastianS3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 2: Surgical Management and Special SituationsJ Crohns Colitis20171113514927660342 </plain></SENT>
</text></ref><ref id="B11"><text><SENT sid="74535" pm="."><plain>11LouisECollardAOgerAFDegrooteEAboul Nasr El YafiFABelaicheJBehaviour of Crohn’s disease according to the Vienna classification: changing pattern over the course of the diseaseGut20014977778211709511 </plain></SENT>
</text></ref><ref id="B12"><text><SENT sid="74536" pm="."><plain>12CosnesJNion-LarmurierIBeaugerieLAfchainPTiretEGendreJPImpact of the increasing use of immunosuppressants in Crohn’s disease on the need for intestinal surgeryGut20055423724115647188 </plain></SENT>
</text></ref><ref id="B13"><text><SENT sid="74537" pm="."><plain>13KlagTWehkampJGoetzMEndoscopic Balloon Dilation for Crohn’s Disease-Associated StricturesClin Endosc20175042943629017297 </plain></SENT>
</text></ref><ref id="B14"><text><SENT sid="74538" pm="."><plain>14BettenworthDGustavssonAAtrejaALopezRTyskCvan AsscheGRiederFA Pooled Analysis of Efficacy, Safety, and Long-term Outcome of Endoscopic Balloon Dilation Therapy for Patients with Stricturing Crohn’s DiseaseInflamm Bowel Dis20172313314228002130 </plain></SENT>
</text></ref><ref id="B15"><text><SENT sid="74539" pm="."><plain>15TharianBCaddyGThamTCEnteroscopy in small bowel Crohn’s disease: A reviewWorld J Gastrointest Endosc2013547648624147191 </plain></SENT>
</text></ref><ref id="B16"><text><SENT sid="74540" pm="."><plain>16HiraiFCurrent status of endoscopic balloon dilation for Crohn’s diseaseIntest Res20171516617328522945 </plain></SENT>
</text></ref><ref id="B17"><text><SENT sid="74541" pm="."><plain>17Morar PS, Faiz O, Warusavitarne J, Brown S, Cohen R, Hind D, Abercrombie J, Ragunath K, Sanders DS, Arnott I, Wilson G, Bloom S, Arebi N; Crohn’s Stricture Study (CroSS) GroupSystematic review with meta-analysis: endoscopic balloon dilatation for Crohn’s disease stricturesAliment Pharmacol Ther2015421137114826358739 </plain></SENT>
</text></ref><ref id="B18"><text><SENT sid="74542" pm="."><plain>18GillRSKaffesAJSmall bowel stricture characterization and outcomes of dilatation by double-balloon enteroscopy: a single-centre experienceTherap Adv Gastroenterol20147108114 </plain></SENT>
</text></ref><ref id="B19"><text><SENT sid="74543" pm="."><plain>19FukumotoATanakaSYamamotoHYaoTMatsuiTIidaMGotoHSakamotoCChibaTSuganoKDiagnosis and treatment of small-bowel stricture by double balloon endoscopyGastrointest Endosc200766S108S11217709019 </plain></SENT>
</text></ref><ref id="B20"><text><SENT sid="74544" pm="."><plain>20NishidaYHosomiSYamagamiHYukawaTNagamiYTanakaFKamataNTanigawaTShibaMWatanabeTAnalysis of the Risk Factors of Surgery after Endoscopic Balloon Dilation for Small Intestinal Strictures in Crohn’s Disease Using Double-balloon EndoscopyIntern Med2017562245225228794359 </plain></SENT>
</text></ref><ref id="B21"><text><SENT sid="74545" pm="."><plain>21ChenMShenBEndoscopic Therapy in Crohn’s Disease: Principle, Preparation, and TechniqueInflamm Bowel Dis2015212222224026284298 </plain></SENT>
</text></ref><ref id="B22"><text><SENT sid="74546" pm="."><plain>22RiederFLatellaGMagroFYukselESHigginsPDDi SabatinoAde BruynJRRimolaJBritoJBettenworthDEuropean Crohn’s and Colitis Organisation Topical Review on Prediction, Diagnosis and Management of Fibrostenosing Crohn’s DiseaseJ Crohns Colitis20161087388526928961 </plain></SENT>
</text></ref><ref id="B23"><text><SENT sid="74547" pm="."><plain>23BettenworthDRiederFMedical therapy of stricturing Crohn’s disease: what the gut can learn from other organs - a systematic reviewFibrogenesis Tissue Repair20147524678903 </plain></SENT>
</text></ref><ref id="B24"><text><SENT sid="74548" pm="."><plain>24LianLStocchiLRemziFHShenBComparison of Endoscopic Dilation vs Surgery for Anastomotic Stricture in Patients With Crohn’s Disease Following Ileocolonic ResectionClin Gastroenterol Hepatol2017151226123127816758 </plain></SENT>
</text></ref><ref id="B25"><text><SENT sid="74549" pm="."><plain>25NelsonRSHernandezAJGoldsteinHMSacaATreatment of irradiation esophagitis. </plain></SENT>
<SENT sid="74550" pm="."><plain>Value of hydrocortisone injectionAm J Gastroenterol1979711723433887 </plain></SENT>
</text></ref><ref id="B26"><text><SENT sid="74551" pm="."><plain>26KochharRPoornachandraKSIntralesional steroid injection therapy in the management of resistant gastrointestinal stricturesWorld J Gastrointest Endosc20102616821160692 </plain></SENT>
</text></ref><ref id="B27"><text><SENT sid="74552" pm="."><plain>27KochharRMakhariaGKUsefulness of intralesional triamcinolone in treatment of benign esophageal stricturesGastrointest Endosc20025682983412447293 </plain></SENT>
</text></ref><ref id="B28"><text><SENT sid="74553" pm="."><plain>28Ramage JI Jr, Rumalla A, Baron TH, Pochron NL, Zinsmeister AR, Murray JA, Norton ID, Diehl N, Romero YA prospective, randomized, double-blind, placebo-controlled trial of endoscopic steroid injection therapy for recalcitrant esophageal peptic stricturesAm J Gastroenterol20051002419242516279894 </plain></SENT>
</text></ref><ref id="B29"><text><SENT sid="74554" pm="."><plain>29RoquesCTéotLThe use of corticosteroids to treat keloids: a reviewInt J Low Extrem Wounds2008713714518611924 </plain></SENT>
</text></ref><ref id="B30"><text><SENT sid="74555" pm="."><plain>30EastJEBrookerJCRutterMDSaundersBPA pilot study of intrastricture steroid versus placebo injection after balloon dilatation of Crohn’s stricturesClin Gastroenterol Hepatol200751065106917627903 </plain></SENT>
</text></ref><ref id="B31"><text><SENT sid="74556" pm="."><plain>31Lichtenstein GR, Hanauer SB, Sandborn WJ; Practice Parameters Committee of American College of GastroenterologyManagement of Crohn’s disease in adultsAm J Gastroenterol200910446583; quiz 464, 48419174807 </plain></SENT>
</text></ref><ref id="B32"><text><SENT sid="74557" pm="."><plain>32Carter MJ, Lobo AJ, Travis SP; IBD Section, British Society of GastroenterologyGuidelines for the management of inflammatory bowel disease in adultsGut200453 Suppl 5V11615306569 </plain></SENT>
</text></ref><ref id="B33"><text><SENT sid="74558" pm="."><plain>33Di NardoGOlivaSPassarielloMPallottaNCivitelliFFredianiSGualdiGGandulliaPMallardoSCucchiaraSIntralesional steroid injection after endoscopic balloon dilation in pediatric Crohn’s disease with stricture: a prospective, randomized, double-blind, controlled trialGastrointest Endosc2010721201120820951986 </plain></SENT>
</text></ref><ref id="B34"><text><SENT sid="74559" pm="."><plain>34BevanRReesCJRutterMDMacafeeDALReview of the use of intralesional steroid injections in the management of ileocolonic Crohn’s stricturesFrontline Gastroenterol2013423824328839732 </plain></SENT>
</text></ref><ref id="B35"><text><SENT sid="74560" pm="."><plain>35SwaminathALichtigerSDilation of colonic strictures by intralesional injection of infliximab in patients with Crohn’s colitisInflamm Bowel Dis20081421321618022870 </plain></SENT>
</text></ref><ref id="B36"><text><SENT sid="74561" pm="."><plain>36SorrentinoDAvelliniCBeltramiCAPasqualEZearoESelective effect of infliximab on the inflammatory component of a colonic stricture in Crohn’s diseaseInt J Colorectal Dis20062127628115951989 </plain></SENT>
</text></ref><ref id="B37"><text><SENT sid="74562" pm="."><plain>37HendelJKarstensenJGVilmannPSerial intralesional injections of infliximab in small bowel Crohn’s strictures are feasible and might lower inflammationUnited European Gastroenterol J20142406412 </plain></SENT>
</text></ref><ref id="B38"><text><SENT sid="74563" pm="."><plain>38ClinicalTrialsgov [Internet]2013Nov 18. </plain></SENT>
<SENT sid="74564" pm="."><plain>IdentifierBethesda (MD)National Library of Medicine (US)NCT01986127, A Randomized, Doubleblinded, Placebo-controlled Study on the Effects of Adalimumab Intralesional Intestinal Strictures of Crohn's Disease Patients; [cited Dec 29, 2017]Available from: <ext-link ext-link-type="uri" xlink:href="https://clinicaltrials.gov/ct2/show/study/NCT01986127ClinicalTrials.gov">https://clinicaltrials.gov/ct2/show/study/NCT01986127 ClinicalTrials.gov</ext-link> </plain></SENT>
</text></ref><ref id="B39"><text><SENT sid="74565" pm="."><plain>39LevineRAWasvaryHKadroOEndoprosthetic management of refractory ileocolonic anastomotic strictures after resection for Crohn’s disease: report of nine-year follow-up and review of the literatureInflamm Bowel Dis20121850651221542067 </plain></SENT>
</text></ref><ref id="B40"><text><SENT sid="74566" pm="."><plain>40AttarAMaunouryVVahediKVernier-MassouilleGVidaSBuloisPColombelJFBouhnik Y;GETAIDSafety and efficacy of extractible self-expandable metal stents in the treatment of Crohn’s disease intestinal strictures: a prospective pilot studyInflamm Bowel Dis2012181849185422161935 </plain></SENT>
</text></ref><ref id="B41"><text><SENT sid="74567" pm="."><plain>41BrancheJAttarAVernier-MassouilleGBuloisPColombelJFBouhnikYMaunouryVExtractible self-expandable metal stent in the treatment of Crohn’s disease anastomotic stricturesEndoscopy201244 Suppl 2 UCTNE325E32623012003 </plain></SENT>
</text></ref><ref id="B42"><text><SENT sid="74568" pm="."><plain>42LorasCPérez-RoldanFGornalsJBBarrioJIgeaFGonzález-HuixFGonzález-CarroPPérez-MirandaMEspinósJCFernández-BañaresFEndoscopic treatment with self-expanding metal stents for Crohn’s disease stricturesAliment Pharmacol Ther20123683383922966851 </plain></SENT>
</text></ref><ref id="B43"><text><SENT sid="74569" pm="."><plain>43KarstensenJGChristensenKRBrynskovJRønholtCVilmannPHendelJBiodegradable stents for the treatment of bowel strictures in Crohn’s disease: technical results and challengesEndosc Int Open20164E296E30027004247 </plain></SENT>
</text></ref><ref id="B44"><text><SENT sid="74570" pm="."><plain>44NavaneethanULourdusamyVNjeiBShenBEndoscopic balloon dilation in the management of strictures in Crohn’s disease: a systematic review and meta-analysis of non-randomized trialsSurg Endosc2016305434544327126619 </plain></SENT>
</text></ref><ref id="B45"><text><SENT sid="74571" pm="."><plain>45MenonAMMirzaAHMoollaSMortonDGAdenocarcinoma of the small bowel arising from a previous strictureplasty for Crohn’s disease: report of a caseDis Colon Rectum20075025725917180254 </plain></SENT>
</text></ref><ref id="B46"><text><SENT sid="74572" pm="."><plain>46PartridgeSKHodinRASmall bowel adenocarcinoma at a strictureplasty site in a patient with Crohn’s disease: report of a caseDis Colon Rectum20044777878115037927 </plain></SENT>
</text></ref><ref id="B47"><text><SENT sid="74573" pm="."><plain>47BarwoodNPlatellCCase report: adenocarcinoma arising in a Crohn’s stricture of the jejunumJ Gastroenterol Hepatol1999141132113410574144 </plain></SENT>
</text></ref><ref id="B48"><text><SENT sid="74574" pm="."><plain>48JaskowiakNTMichelassiFAdenocarcinoma at a strictureplasty site in Crohn’s disease: report of a caseDis Colon Rectum20014428428711227948 </plain></SENT>
</text></ref><ref id="B49"><text><SENT sid="74575" pm="."><plain>49CollierPETurowskiPDiamondDLSmall intestinal adenocarcinoma complicating regional enteritisCancer1985555165213965106 </plain></SENT>
</text></ref><ref id="B50"><text><SENT sid="74576" pm="."><plain>50Ribeiro MB, Greenstein AJ, Heimann TM, Yamazaki Y, Aufses AH JrAdenocarcinoma of the small intestine in Crohn’s diseaseSurg Gynecol Obstet19911733433491948581 </plain></SENT>
</text></ref><ref id="B51"><text><SENT sid="74577" pm="."><plain>51GustavssonAMagnusonABlombergBAnderssonMHalfvarsonJTyskCEndoscopic dilation is an efficacious and safe treatment of intestinal strictures in Crohn’s diseaseAliment Pharmacol Ther20123615115822612326 </plain></SENT>
</text></ref><ref id="B52"><text><SENT sid="74578" pm="."><plain>52BlombergBRolnyPJärnerotGEndoscopic treatment of anastomotic strictures in Crohn’s diseaseEndoscopy1991231951981915133 </plain></SENT>
</text></ref><ref id="B53"><text><SENT sid="74579" pm="."><plain>53WilliamsAJPalmerKREndoscopic balloon dilatation as a therapeutic option in the management of intestinal strictures resulting from Crohn’s diseaseBr J Surg1991784534542032105 </plain></SENT>
</text></ref><ref id="B54"><text><SENT sid="74580" pm="."><plain>54BreysemYJanssensJFCoremansGVantrappenGHendrickxGRutgeertsPEndoscopic balloon dilation of colonic and ileo-colonic Crohn’s strictures: long-term resultsGastrointest Endosc1992381421471568610 </plain></SENT>
</text></ref><ref id="B55"><text><SENT sid="74581" pm="."><plain>55CouckuytHGeversAMCoremansGHieleMRutgeertsPEfficacy and safety of hydrostatic balloon dilatation of ileocolonic Crohn’s strictures: a prospective longterm analysisGut1995365775807737567 </plain></SENT>
</text></ref><ref id="B56"><text><SENT sid="74582" pm="."><plain>56RamboerCVerhammeMDhondtEHuysSVan EygenKVermeireLEndoscopic treatment of stenosis in recurrent Crohn’s disease with balloon dilation combined with local corticosteroid injectionGastrointest Endosc1995422522557498692 </plain></SENT>
</text></ref><ref id="B57"><text><SENT sid="74583" pm="."><plain>57MatsuiTIkedaKTsudaSYaoKSouSSatohSHatakeyamaSMatakeHSakuraiTYaoTLong-term outcome of endoscopic balloon dilation in obstructive gastrointestinal Crohn’s disease: a prospective long-term studyDiagn Ther Endosc20006677518493528 </plain></SENT>
</text></ref><ref id="B58"><text><SENT sid="74584" pm="."><plain>58DearKLHunterJOColonoscopic hydrostatic balloon dilatation of Crohn’s stricturesJ Clin Gastroenterol20013331531811588547 </plain></SENT>
</text></ref><ref id="B59"><text><SENT sid="74585" pm="."><plain>59BrookerJCBeckettCGSaundersBPBensonMJLong-acting steroid injection after endoscopic dilation of anastomotic Crohn’s strictures may improve the outcome: a retrospective case seriesEndoscopy20033533333712664391 </plain></SENT>
</text></ref><ref id="B60"><text><SENT sid="74586" pm="."><plain>60MoriniSHassanCLorenzettiRZulloACerroPWinnSGiustiniMTaggiFLong-term outcome of endoscopic pneumatic dilatation in Crohn’s diseaseDig Liver Dis20033589389714703886 </plain></SENT>
</text></ref><ref id="B61"><text><SENT sid="74587" pm="."><plain>61SabatéJMVillarejoJBouhnikYAllezMGornetJMVahediKModiglianiRLémannMHydrostatic balloon dilatation of Crohn’s stricturesAliment Pharmacol Ther20031840941312940926 </plain></SENT>
</text></ref><ref id="B62"><text><SENT sid="74588" pm="."><plain>62Thomas-GibsonSBrookerJCHaywardCMShahSGWilliamsCBSaundersBPColonoscopic balloon dilation of Crohn’s strictures: a review of long-term outcomesEur J Gastroenterol Hepatol20031548548812702904 </plain></SENT>
</text></ref><ref id="B63"><text><SENT sid="74589" pm="."><plain>63SinghVVDraganovPValentineJEfficacy and safety of endoscopic balloon dilation of symptomatic upper and lower gastrointestinal Crohn’s disease stricturesJ Clin Gastroenterol20053928429015758621 </plain></SENT>
</text></ref><ref id="B64"><text><SENT sid="74590" pm="."><plain>64AjlouniYIserJHGibsonPREndoscopic balloon dilatation of intestinal strictures in Crohn’s disease: safe alternative to surgeryJ Gastroenterol Hepatol20072248649017376038 </plain></SENT>
</text></ref><ref id="B65"><text><SENT sid="74591" pm="."><plain>65FerlitschAReinischWPüspökADejacoCSchillingerMSchöflRPötziRGanglAVogelsangHSafety and efficacy of endoscopic balloon dilation for treatment of Crohn’s disease stricturesEndoscopy20063848348716767583 </plain></SENT>
</text></ref><ref id="B66"><text><SENT sid="74592" pm="."><plain>66NomuraETakagiSKikuchiTNegoroKTakahashiSKinouchiYHiwatashiNShimosegawaTEfficacy and safety of endoscopic balloon dilation for Crohn’s stricturesDis Colon Rectum200649S59S6717106817 </plain></SENT>
</text></ref><ref id="B67"><text><SENT sid="74593" pm="."><plain>67FosterENQuirosJAPrindivilleTPLong-term follow-up of the endoscopic treatment of strictures in pediatric and adult patients with inflammatory bowel diseaseJ Clin Gastroenterol20084288088518645528 </plain></SENT>
</text></ref><ref id="B68"><text><SENT sid="74594" pm="."><plain>68HoffmannJCHellerFFaissSvon LampeBKroesenAJWahnschaffeUSchulzkeJDZeitzMBojarskiCThrough the endoscope balloon dilation of ileocolonic strictures: prognostic factors, complications, and effectivenessInt J Colorectal Dis20082368969618338175 </plain></SENT>
</text></ref><ref id="B69"><text><SENT sid="74595" pm="."><plain>69StieneckerKGleichmannDNeumayerUGlaserHJTonusCLong-term results of endoscopic balloon dilatation of lower gastrointestinal tract strictures in Crohn’s disease: a prospective studyWorld J Gastroenterol2009152623262719496192 </plain></SENT>
</text></ref><ref id="B70"><text><SENT sid="74596" pm="."><plain>70MuellerTRiederBBechtnerGPfeifferAThe response of Crohn’s strictures to endoscopic balloon dilationAliment Pharmacol Ther20103163463920047581 </plain></SENT>
</text></ref><ref id="B71"><text><SENT sid="74597" pm="."><plain>71ThienpontCD’HooreAVermeireSDemedtsIBisschopsRCoremansGRutgeertsPVan AsscheGLong-term outcome of endoscopic dilatation in patients with Crohn’s disease is not affected by disease activity or medical therapyGut20105932032419840991 </plain></SENT>
</text></ref><ref id="B72"><text><SENT sid="74598" pm="."><plain>72ScimecaDMocciaroFCottoneMMontalbanoLMD’AmicoGOlivoMOrlandoROrlandoAEfficacy and safety of endoscopic balloon dilation of symptomatic intestinal Crohn’s disease stricturesDig Liver Dis20114312112520561831 </plain></SENT>
</text></ref><ref id="B73"><text><SENT sid="74599" pm="."><plain>73KarstensenJGHendelJVilmannPEndoscopic balloon dilatation for Crohn’s strictures of the gastrointestinal tract is feasibleDan Med J201259A447122759846 </plain></SENT>
</text></ref><ref id="B74"><text><SENT sid="74600" pm="."><plain>74de’AngelisNCarraMCBorrelliOBizzarriBVincenziFFornaroliFDe CaroGde’AngelisGLShort- and long-term efficacy of endoscopic balloon dilation in Crohn’s disease stricturesWorld J Gastroenterol2013192660266723674873 </plain></SENT>
</text></ref><ref id="B75"><text><SENT sid="74601" pm="."><plain>75EndoKTakahashiSShigaHKakutaYKinouchiYShimosegawaTShort and long-term outcomes of endoscopic balloon dilatation for Crohn’s disease stricturesWorld J Gastroenterol201319869123326167 </plain></SENT>
</text></ref><ref id="B76"><text><SENT sid="74602" pm="."><plain>76HonzawaYNakaseHMatsuuraMHiguchiHToyonagaTMatsumuraKYoshinoTOkazakiKChibaTPrior use of immunomodulatory drugs improves the clinical outcome of endoscopic balloon dilation for intestinal stricture in patients with Crohn’s diseaseDig Endosc20132553554323363364 </plain></SENT>
</text></ref><ref id="B77"><text><SENT sid="74603" pm="."><plain>77NandaKCourtneyWKeeganDByrneKNolanBO’DonoghueDMulcahyHDohertyGProlonged avoidance of repeat surgery with endoscopic balloon dilatation of anastomotic strictures in Crohn’s diseaseJ Crohns Colitis2013747448022898397 </plain></SENT>
</text></ref><ref id="B78"><text><SENT sid="74604" pm="."><plain>78AtrejaAAggarwalADwivediSRiederFLopezRLashnerBABrzezinskiAVargoJJShenBSafety and efficacy of endoscopic dilation for primary and anastomotic Crohn’s disease stricturesJ Crohns Colitis2014839240024189349 </plain></SENT>
</text></ref><ref id="B79"><text><SENT sid="74605" pm="."><plain>79BhalmeMSarkarSLalSBodgerKBakerRWillertRPEndoscopic balloon dilatation of Crohn’s disease strictures: results from a large United kingdom seriesInflamm Bowel Dis20142026527024374876 </plain></SENT>
</text></ref><ref id="B80"><text><SENT sid="74606" pm="."><plain>80HagelAFHahnADauthWMatzelKKonturekPCNeurathMFRaithelMOutcome and complications of endoscopic balloon dilatations in various types of ileocaecal and colonic stenosis in patients with Crohn’s diseaseSurg Endosc2014282966297224853850 </plain></SENT>
</text></ref><ref id="B81"><text><SENT sid="74607" pm="."><plain>81KraussEAgaimyAGottfriedAMaissJWeidingerTAlbrechtHHartmannAHohenbergerWNeurathMFKesslerHLong term follow up of through-the-scope balloon dilation as compared to strictureplasty and bowel resection of intestinal strictures in crohn’s diseaseInt J Clin Exp Pathol201477419743125550777 </plain></SENT>
</text></ref><ref id="B82"><text><SENT sid="74608" pm="."><plain>82DingNSYipWMChoiCHSaundersBThomas-GibsonSArebiNHumphriesAHartAEndoscopic Dilatation of Crohn’s Anastomotic Strictures is Effective in the Long Term, and Escalation of Medical Therapy Improves Outcomes in the Biologic EraJ Crohns Colitis2016101172117826971054 </plain></SENT>
</text></ref></ref-list></SecTag></back></article>
